Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsSelectHealth formulary coverage & Prior Auth Updat…
    Ask Trek AI about this page
    CurrentSelectHealthPolicy N/A

    Prescription drug list (formulary) — Coverage Criteria

    Customize your policy alerts

    Sign up for all SelectHealth policy alerts

    Know when SelectHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document summarizes commonly prescribed drugs covered by SelectHealth plans, including tier placement, requirements (e.g., prior authorization, step therapy, quantity limits, age limits), and instructions for members and providers on coverage and exceptions.

    Policy Summary
    PayerSelectHealth
    PolicyPrescription drug list (formulary) — Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJan 1, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization for drugs listed with (PA) before submitting claims to avoid denial or member financial responsibility.
    SourceLink

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    monthlyformulary review frequency
    90-daymaintenance drug supply option
    800-538-5038Pharmacy Services
    partialdocument part
    PA, ST, QL, AGE, Mrequirement flags

    Formulary Coverage Principles

    Drugs that are not listed on the SelectHealth formulary are noncovered by default. Coverage may be granted on a case‑by‑case basis when medical necessity is demonstrated; the member, prescribing clinician, or pharmacy may submit a Drug Coverage Exception Form for review.

    Provider Requirements, Prior Authorization, and Utilization Management

    Note

    Prior authorization and plan requirement indicators

    Some drugs in the formulary are annotated with plan requirement flags — (PA), (QL), (M), (AGE), and (ST). These flags indicate prior authorization, quantity limits, medication management documentation, age restrictions, and step therapy requirements respectively. Verify the flag(s) shown for a drug before prescribing or billing to determine what actions or documentation are needed.

    • (PA) = Prior authorization required before coverage; without approval the member may be responsible for full retail cost.
    • (QL) = Quantity limits enforced; quantities above the limit require preauthorization and may be denied.
    • (M) = Medical management/documentation may be required to support medical necessity.
    • (AGE) = Coverage limited by patient age; verify the member meets age criteria.
    • (ST) = Step therapy required; alternative therapy trials and failure documentation may be required.
    Prior Authorization

    Prior authorization required for selected specialty agents

    Selected specialty injectables and other high-cost agents are specifically marked with (PA) and require prior authorization before the plan will cover them. Obtain prior authorization prior to dispensing or administering these specialty agents to avoid claim denials and member liability.

    • Examples in the formulary include Repatha Injectable / Repatha Sure Injectable and other specialty injectables marked (PA).
    • High-cost specialty drugs across therapeutic classes may carry (PA) — check the drug entry for the flag.
    Prior Authorization

    Prior authorization/age restrictions for select injectables

    Certain injectables and vaccines include age-based restrictions (AGE) and/or other Requirements & Limits flags. Confirm the member's age and any associated documentation before administering or billing these products.

    • Vaccines such as Gardasil 9, Prevnar 23, Comirnaty and others show (AGE) where applicable.
    • Many injectables list (QL) and (M) in addition to (AGE) — review all flags on the drug entry.
    Denial Risk

    Quantity limits enforcement

    Quantity limits (QL) are actively enforced on many agents (for example, opioids, select injectables, and certain chronic therapies). If the requested quantity exceeds the plan limit, submit a prior authorization request and supporting documentation; failure to do so may result in denial or the member being billed.

    • Examples: opioids and select chronic therapies are shown with (QL).
    • Repatha Injectable and Repatha Sure Injectable include (QL) alongside (PA) and (M).
    • If the pharmacy exceeds the plan QL at point of sale, the claim may reject — obtain PA to override limits.
    Prior Authorization

    PA and QL for Mounjaro

    Mounjaro Injectable is listed with (PA)(QL)(M) in the formulary. Prior authorization is required for coverage, quantity limits apply, and medical management documentation may be requested to demonstrate medical necessity.

    • Before initiating Mounjaro, confirm PA approval and that requested quantity is within plan limits or supported by PA documentation.
    • Include clinical rationale and prior therapy history as part of the PA submission to address the (M) documentation requirement.
    Note

    Prior authorization and other requirement indicators present

    The formulary uses combined flags across many drug entries — (PA),(QL),(M),(AGE),(ST) — which can affect coverage determinations and claims processing. Always review the Requirements & Limits column on the drug entry to determine applicable conditions and next steps.

    • Many drugs across classes (e.g., HIV agents, inhalers, CV agents, injectables) show combinations of flags such as (PA)(QL)(M).
    • Failure to satisfy the indicated requirements may result in claim denial or member financial responsibility.
    Denial Risk

    Requirements & Limits may trigger denial

    Drugs annotated with Requirements & Limits flags may be denied if the specified conditions are not met. Submit complete documentation and, when applicable, a prior authorization before dispensing to reduce denial risk.

    • Common denial triggers: PA not obtained; requested quantity exceeds QL without PA; age restriction not met; step therapy requirements not satisfied.
    • When a claim is denied for not meeting Requirements & Limits, the member may be liable for the cost.
    Note

    Coverage exception process

    For drugs that are not covered, or when coverage is denied, providers, members, or pharmacies may request a Drug Coverage Exception based on medical necessity. Use the plan's Drug Coverage Exception Form available on the payer website and include clinical documentation supporting the exception request.

    • Submit supporting clinical records, rationale for the requested non‑formulary drug, and prior therapy history.
    • The exception request is reviewed case-by-case; approval is not guaranteed and is based on medical necessity.
    Documentation Required

    Documentation for QL/M/AGE

    When a drug entry shows (QL), (M), or (AGE), include explicit documentation to justify the request: e.g., quantities needed and frequency (for QL), clinical rationale and prior treatment attempts (for M), and patient date of birth or age-specific indication (for AGE). Incomplete documentation increases the chance of denial.

    • For QL overrides, provide exact dosing schedule and clinical justification for higher quantity.
    • For (M) flags, attach relevant clinical notes, labs, prior authorization forms, and progress notes showing medical necessity.
    • For (AGE) flags, include the patient’s DOB and evidence the patient meets the indicated age criteria.
    Documentation Required

    Documentation expectations for QL/M entries

    When (QL) or (M) appear on an entry, be prepared to supply supporting evidence as part of any prior authorization or exception request. The plan may require objective clinical data or documentation of failure/intolerance to preferred therapies.

    • Typical supporting documentation: treatment history, lab results, specialist notes, and reason why preferred/step therapies were inappropriate or failed.
    • Documentation should directly address the specific Requirement & Limits flags shown on the drug entry.
    Billing Rule

    Check Requirements & Limits annotations

    Before prescribing or submitting a claim, check the drug's Requirements & Limits annotations on the formulary entry. Confirm whether (PA),(QL),(M),(AGE),(ST) apply and follow the plan's operational steps — obtain PA, supply documentation, or confirm age/step therapy status as required.

    • Verify the drug entry in the formulary or the plan's prior authorization tool for up-to-date flags.
    • If multiple flags apply (e.g., (PA)(QL)(M)), address all requirements in the PA submission to avoid incomplete reviews.
    Step Therapy

    Step therapy requirement

    Step therapy (ST) requires that members try and fail specified alternative therapies before the requested drug is covered. Coverage will generally follow documentation that an appropriate alternative was ineffective or not tolerated. Step therapy most commonly applies to brand-name drugs.

    • When a drug is marked (ST), include trial dates, duration, and reason for failure or intolerance to the step drug in the PA or exception submission.
    • Examples of ST flags appear in the formulary (e.g., certain acne agents, some migraine agents, and select CNS agents).
    Step Therapy

    Step therapy flags present

    Numerous formulary entries display (ST) alongside other flags. Identify these step therapy flags early in treatment planning to avoid delays. If step therapy is required, document the required prior therapy and outcome in any authorization request.

    • Examples in the formulary include Adapalene Gel (ST), Clindamy/Ben Gel (ST), some migraine agents (e.g., Frovatriptan noted with ST), and select CNS medications.
    • For ST denials, use the Drug Coverage Exception Form to request coverage if clinical justification supports bypassing the step requirement.
    Documentation Required

    Several CNS and other agents show (M) and (QL)

    Some CNS and other agents frequently display (M) and (QL) flags indicating medical management and quantity limits. Anticipate requests for clinical documentation (e.g., treatment history, dosing justification) when prescribing these agents to ensure timely review and reduce denial risk.

    • CNS examples include memantine products, many antidepressants/antipsychotics with (M) and/or (QL).
    • Prepare to submit clinical notes, prior therapy trials, and objective measures when (M) is present.

    Formulary Structure and Scope

    The formulary groups medications by therapeutic category and identifies each product’s tier and any utilization management controls. Expect to see flags such as PA (preauthorization), ST (step therapy), QL (quantity limits), AGE (age limits), and M (maintenance/medical edit) on listed drugs to indicate plan requirements that must be met for coverage.

    Abbreviations and Requirement Codes

    Formulary requirement codes — key definitions for PA, M, ST, QL, AGE
    PAPreauthorization required — coverage requires preauthorization from the plan; without it the member may be responsible for full retail price.
    MMaintenance drug — eligible for extended fill (may allow a 90‑day supply).
    STStep therapy — coverage only after trial and failure or intolerance of specified alternative therapy (often applies to brand drugs).
    QLQuantity Limits — plan limits on amount dispensed; preauthorization required if medication exceeds plan limits.
    AGEAge limit — a minimum or maximum age requirement must be met for coverage of the product.
    PA, QL, ST, AGE, M — abbreviated flags used throughout the list

    Step Therapy Requirements and Affected Drugs

    Drug / exampleRequirements & Limits
    Dilt-Xr Capsule (example)
    (ST)(QL)(M) — step therapy required; quantity limits and medical edit may apply
    Pitavastatin Tablet (example)
    (ST)(QL)(M) — step therapy required; quantity limits and medical edit may apply
    ProductFormulary flags
    Dilt-Xr Capsule
    (ST)(QL)(M) — listed with step therapy, quantity limit, and medical edit
    Pitavastatin Tablet
    (ST)(QL)(M) — listed with step therapy, quantity limit, and medical edit
    Adapalene Gel
    (ST) — listed with step therapy requirement
    Product / classIndicator
    Savella Tablet (CNS)
    (ST)(QL)(M) — step therapy plus QL and medical edit indicated
    Eletriptan / Migraine agents
    (QL) — quantity limits indicated; some migraine agents elsewhere show (ST)
    General Step Therapy definition
    (ST) — step therapy applies to listed products (see formulary entries)
    Drug / exampleRequirements & Limits
    Modafinil Tablet (CNS example)
    (QL)(M) — quantity limits and medical edit indicated
    Pilocarpine Tablet
    (QL)(M) — quantity limits and medical edit indicated
    Armour Thyro Tablet (Thyroid example)
    (M) — medical edit / medical necessity review indicated

    Quantity Limits and Affected Products

    Auvi-Q/Epinephrine injectables — quantity limits apply (QL indicated)
    Auvi‑Q InjectableRequirements & Limits = (QL) — quantity limits apply to Auvi‑Q injectable devices.
    Epinephrine InjectableRequirements & Limits = (QL) — quantity limits also indicated for generic epinephrine injectables.
    ContextBoth products are listed within ANAPHYLAXIS THERAPY AGENTS and show QL in the Requirements & Limits field.
    Multiple antiretroviral tablets (Biktarvy, Genvoya, Isentress) — QL and M indicated for some entries
    BiktarvyRequirements & Limits = (QL)(M) — quantity limits and maintenance/medical edit flagged for Biktarvy Tablet.
    GenvoyaRequirements & Limits = (QL)(M) — quantity limits and maintenance flagged for Genvoya Tablet.
    Policy Summary
    PayerSelectHealth
    PolicyPrescription drug list (formulary) — Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJan 1, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization for drugs listed with (PA) before submitting claims to avoid denial or member financial responsibility.
    SourceLink
    On This Page
    Formulary Coverage PrinciplesProvider Requirements, Prior Authorization, and Utilization ManagementFormulary Structure and ScopeAbbreviations and Requirement CodesStep Therapy Requirements and Affected DrugsQuantity Limits and Affected Products
    PAAbbreviated flag used to indicate prior authorization is required for the listed product.
    QLIndicates quantity limits apply to the listed product (see product row for specifics).
    STIndicates step therapy is required before coverage of the listed product.
    AGEIndicates an age-based coverage requirement is specified for the listed product.
    MIndicates maintenance / medical edit flag; may allow 90‑day supply or require medical necessity review.
    (PA) — Prior authorization required indicator
    (PA)Prior authorization required for coverage; absence of PA may result in claim denial or member being responsible for full retail cost.
    ScopeUsed on multiple product entries to indicate PA is a condition of coverage and may be paired with other flags (QL, M, AGE).
    ActionProviders should submit prior authorization documentation per plan process before dispensing to avoid denial.
    (QL) — Quantity limits indicator
    (QL)Quantity limits apply — plan sets limits on the amount of drug dispensed (per timeframe or course); exceeding limits may require preauthorization.
    ExamplesAuvi‑Q, many antivirals (e.g., Paxlovid) and multiple inhalation and vaccine entries are annotated with (QL).
    DocumentationRequests that exceed QL require justification and may trigger medical necessity review when submitted for PA.
    (M) — Medical edit / maintenance drug indicator
    (M)Maintenance drug / medical edit — may allow extended (90‑day) supply and/or require medical necessity review for coverage.
    ImplicationEntries flagged (M) often require documentation of ongoing therapy and may affect dispensing quantity (e.g., 90‑day fills).
    ExamplesMultiple chronic therapy agents (antiretrovirals, diabetes agents, thyroid supplements, vitamins) are annotated with (M).
    (AGE) — Age limit indicator
    (AGE)Age limit — a minimum or maximum patient age must be met for the product to be covered (product row will specify applicable ages).
    ApplicationCommon for vaccines and pediatric formulations (e.g., Pneumovax, Gardasil, pediatric iron products) where age determines coverage.
    VerificationProviders should confirm patient age against the product's AGE requirement before submitting a claim or PA request.
    (ST) — Step therapy indicator
    (ST)Step therapy required — coverage only after documented trial and failure or intolerance of required alternative therapy.
    Typical useOften applied to brand‑name drugs and select therapeutic classes; entries show (ST) sometimes combined with (QL) and (M).
    Provider actionDocument prior therapy attempts and reasons for failure/intolerance when submitting a PA or exception for an ST product.
    IsentressRequirements & Limits = (QL)(M) — Isentress Tablet entries indicate QL and M flags.
    Multiple entries — items indicated by (QL)
    AirSupra InhalationRequirements & Limits = (QL) — inhalation products in COPD/asthma categories show QL flags.
    AlbuterolRequirements & Limits = (QL)(M) — indicates both quantity limits and maintenance edit for common rescue inhaler entries.
    Repatha InjectableRequirements & Limits = (PA)(QL)(M) — Repatha products include QL among other flags.
    Multiple listed products — QL indicated
    Linzess (linaclotide)Listed under Quintet Ac Tes with Requirements & Limits = (PA)(QL)(M) — QL indicated among other flags.
    LubiprostoneListed with Requirements & Limits = (QL)(M)(AGE) in some rows — quantity limits noted.
    Ondansetron / AntivertAppear in Relion product groups with Requirements & Limits = (PA)(QL)(M) or (PA)(QL)(M) variations — QL present across multiple grouped products.
    Various vaccines and pediatric iron products — annotated with (QL) or (AGE) where specified
    Comirnaty / Pfizer vaccine formulationsRequirements & Limits include (QL) for several age/formulation rows (e.g., Comirnaty, Pfizer pediatric formulations).
    Gardasil 9 / Pneumovax / ShingrixSome vaccines list (AGE) and/or (QL) and (AGE) (e.g., Gardasil 9 = (AGE), Shingrix = (QL)(AGE), Pneumovax 23 = (AGE)).
    Pediatric iron productsFe‑Vite, Ferrous Sul solutions, Iron Drops, Pedia Iron Drop rows include (QL)(AGE) indicating both quantity and age limits for pediatric formulations.